Hi Potstock,
My initial post (below) was really just indicating how cheap we are now, questioning the lack of interest off the back of the over subscribed Capital raise. I used a a general figure of $4-5 if we have success, it seemed realistic from $2.00 on the day of posting with the buys/sell side stacked the way it was.
I guess i was just trying to indicate the conservative upside on display here now 2 months out from results, questioning why are punters basically not all over this driving the share price up on a stock with low SOI by wanting a piece of the action as we are potentially on the cusp of a company making announcement.
Truth is i don't know and nor does anyone else know what share price will be in the event there is a successful announcement for phase 3 trof, market will decide in the end.
The $3.50 share price pre potential pharma deal you refer too, is the essence of my initial post, as it seems logical to me that we are now close to a potential company making announcement with a great US deal structure leaving us atm full ROW rights is far greater position than a potential pharma deal back then.
Professional analysts have us at $3,90 or something per share 6months ago, they are using reasonable metrics for these assumptions.
I agree with all your points, personally i feel like we should be around $3.90 today and if successful with phase 3, off the back of the announcement $5-$6 , reality is we are $2.05 today 2 months out from Phase 3 results
"Yeah we are now in Q4 results due this quarter.
Share price is going the wrong way, buy vs sell depth is 92 buyers to 350k sellers, LOL
Neu is $4-5 p/sh if successful phase 3 trial from Trof, where are all the buyers that missed out, the CR was oversubscribed?"
- Forums
- ASX - By Stock
- NEU
- Ann: Phase 3 enrolment successfully completed, results in Q4 2021
Ann: Phase 3 enrolment successfully completed, results in Q4 2021, page-90
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B |
Open | High | Low | Value | Volume |
$14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $13.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.07 | 6644 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 13.990 |
1 | 300 | 13.970 |
1 | 1432 | 13.950 |
2 | 1230 | 13.900 |
1 | 720 | 13.890 |
Price($) | Vol. | No. |
---|---|---|
14.420 | 175 | 1 |
14.500 | 2985 | 2 |
14.800 | 2850 | 2 |
14.860 | 500 | 1 |
14.960 | 445 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |